Pre-mRNA splicing is an important step in eukaryotic gene expression, whereby non-coding introns are removed from newly synthesized pre-mRNA by two step-wise trans-esterification reactions. Intron excision is catalysed by the spliceosome, a large and dynamic ribonucleoprotein particle (RNP) that assembles anew on each intron[@R1]. First, U1 and U2 snRNPs recognise the pre-mRNA 5'-splice site (5'SS) and the branch point sequence, forming the A complex, which associates with U4/U6.U5 tri-snRNP to form pre-B complex[@R2]. The 5\'SS--U1 snRNP interaction is then disrupted by the helicase Prp28 (ref.[@R3]) and the 5'SS is transferred to the U6 snRNA ACAGAGA region[@R4], forming the pre-catalytic B complex. Spliceosome activation requires the proteins Spp381, Prp38, and Snu23 (ref.[@R5],[@R6]) and is initiated by ATP-dependent unwinding of the U4/U6 duplex by the helicase Brr2 (ref.[@R7],[@R8]). During this process U4 snRNA and U4/U6 di-snRNP proteins dissociate[@R9],[@R10] and nineteen- and nineteen-related (NTC and NTR)[@R9],[@R11],[@R12] complex proteins are recruited. U6 snRNA, freed from U4 snRNA, forms an internal stem loop and the U2/U6 helix I with U2 snRNA[@R13], yielding the catalytic RNA centre that harbours the catalytic metal ions[@R14],[@R15]. This activated spliceosome, B^act^, is then converted to B\*, positioning the branch point adenosine at the 5'SS for step 1 of splicing (branching). The resultant C complex is remodelled to C\*, bringing the 5'- and 3'-exons into proximity for step 2 of splicing (exon ligation)[@R16],[@R17]. Ligated mRNA is then released and the intron-lariat spliceosome (ILS) is disassembled to recycle snRNPs for further splicing rounds.

Recent cryo-electron microscopy (cryo-EM) studies of yeast[@R18]--[@R23] and human spliceosomes[@R24] have provided unprecedented insights into the catalytic stages of splicing. The group II intron-like catalytic RNA centre is fully formed in B^act^ (ref.[@R20],[@R21]) with pre-mRNA 5'SS positioned near the catalytic metals and the branch point adenosine located 50Å away. The C and C\* complex structures[@R18],[@R19],[@R22]--[@R24] revealed step I and step II conformations and the functions of step-specific factors. In contrast, the molecular details prior to the catalytic stages are less well understood. Although the structures of isolated tri-snRNP[@R25]--[@R27] and several U2 snRNP parts are available[@R21],[@R28]--[@R30], low resolution structures of complete yeast[@R9],[@R31] and human[@R32],[@R33] pre-catalytic spliceosomes provided only limited insights into their assembly and activation.

Here we report the cryo-EM structure of the pre-catalytic B-complex from the yeast *Saccharomyces cerevisiae* at near-atomic resolution, revealing the complete U2 snRNP architecture and its interactions with U4/U6.U5 tri-snRNP. Comparison with the yeast B^act^ structure[@R20],[@R21] provides crucial insights into the mechanism of spliceosome activation.

Overall architecture and U2 snRNP {#S1}
=================================

We assembled spliceosomes on *UBC4* pre-mRNA and stalled at the B complex stage by limiting ATP concentration[@R9],[@R34] ([Methods](#S6){ref-type="sec"}). Spliceosomes were imaged under cryogenic conditions yielding 496,581 single particle images ([Extended Data Fig. 1d](#F7){ref-type="fig"}). Several rounds of unsupervised 2D and 3D particle sorting, focused refinement, and signal subtraction produced cryo-EM densities for the complete B-complex structure ([Fig. 1](#F1){ref-type="fig"}, [Extended Data Figs 1e, f](#F7){ref-type="fig"}, [2](#F8){ref-type="fig"}, [3](#F9){ref-type="fig"}, [Methods](#S6){ref-type="sec"}) ranging from 3.6--17.2 Å resolution (maps B1-7). In B complex the U2 snRNP resides between the tri-snRNP 'head' and 'arm' regions[@R26],[@R27], in agreement with low-resolution studies of yeast and human complexes[@R31],[@R32],[@R35] ([Fig. 1](#F1){ref-type="fig"}, [Supplementary information](#SD2){ref-type="supplementary-material"}). B complex has a concave shape, formed in part by the U2 snRNP that protrudes over the tri-snRNP region, where the catalytic centre will be created. The yeast U2 snRNP contains 18 proteins, divided into 7 Sm proteins, the Msl1-Lea1 hetero-dimer, SF3a (Prp9, Prp11, Prp21), and SF3b (Hsh155, Rse1, Cus1, Hsh49, Rds3, Ysf3) subcomplexes ([Fig. 2a](#F2){ref-type="fig"}, [Extended Data Fig. 4](#F10){ref-type="fig"}). Consistent with negative stain EM of its human counterpart[@R36] the yeast U2 snRNP has a bipartite structure, consisting of 5' (or SF3b-bound) and 3' domains (Sm core domain and the Msl1-Lea1 dimer). The elongated SF3a subcomplex bridges the two domains, and U2 snRNA in between adopts the stem IIa/b configuration[@R1] ([Fig. 2a](#F2){ref-type="fig"}, [Extended Data Fig. 4c](#F10){ref-type="fig"}). The SF3b subcomplex is organised around Rse1, comprising three β-propeller domains BPA, BPB, and BPC, and the split washer-shaped HEAT-repeat protein Hsh155 that together envelop Ysf3 and the Zn-containing Rds3[@R20],[@R21],[@R30]. The pre-mRNA branch point sequence and U2 snRNA form the branch helix, which is wedged into the split ends of the Hsh155 HEAT-repeats as in B^act^ (ref.[@R20],[@R21]). The nucleotide base of the branch point adenosine (A70) is flipped out of the branch helix and makes contact with Tyr35 of Rds3 and a pocket formed by HEAT repeats H15-17 of Hsh155 as in B^act^.

The U2 3' domain and SF3a subcomplexes associate via contacts between the Prp9 Zn-finger 1 (ZnF1) and U2 Sm ring subunits SmD1 and SmD2. SF3a bridges the 5' and 3' domains[@R36] via the conserved Prp9 ZnF2 and Prp11 ZnF, which are anchored largely by SF3b subunit Cus1, U2 snRNA stem IIa/b, and the intron ([Fig. 2b](#F2){ref-type="fig"}). This explains why the Prp9 ZnF2 and Prp11 ZnF are required for SF3a integration into the human U2 snRNP and for A complex assembly[@R37]. The intron upstream of the branch helix is chaperoned by the Prp11 ZnF and a conserved α-helix in Prp9 (residues 407-415) that we term 'wedge helix' ([Fig. 2b](#F2){ref-type="fig"}). The wedge helix binds U2 stem IIa, and separates the intron (position --12 from the branch point) from U2 snRNA, guiding the intron towards its binding site on the SF3b Hsh49 RNA recognition motif 1 (RRM1) (around position --17). Hsh49 RRM1 connects to RRM2, which rests on top of the Prp9 ZnF2 domain and binds U2 stem IIb. Thus, both Hsh49 RRM domains bind to RNA, and mutation of these interfaces is lethal in yeast[@R38]. The SF3b protein Cus1 forms an extended polypeptide that folds onto Hsh155 H16-20 and the Rse1 BPC. Anchored at this site, Cus1 (residues 290-353) forms a globular domain with Hsh49 RRM1 (ref.[@R28]) and nearby Cus1 regions bind Prp9 ZnF2, Prp11 ZnF as well as U2 stem IIa ([Fig. 2b](#F2){ref-type="fig"}). Cus1 thereby scaffolds key U2 snRNA and pre-mRNA interactions. The structure thus reveals how SF3a and SF3b form an intricate network of protein-RNA interactions to chaperone U2 snRNA and the intron[@R38]--[@R41].

B complex stabilization {#S2}
=======================

The U2 snRNP 5' domain binds to tri-snRNP through two interfaces (A and B, [Fig. 3a](#F3){ref-type="fig"}, [Extended Data Fig. 5a](#F11){ref-type="fig"}). In interface A, the SF3b subunit Hsh155 binds to the U4/U6 di-snRNP protein Prp3 ([Fig. 3b](#F3){ref-type="fig"}). A long α-helix of Prp3 (α4) extends from the Prp4 β-propeller domain toward the U6 LSm ring (LSm5 and LSm7 subunits), reaches across the LSm ring, and inserts its putative N-terminal helices between the LSm ring subunit LSm2 and the Hsh155 HEAT repeats H11-13 ([Fig. 3a, b](#F3){ref-type="fig"}). Interface A further involves U2/U6 helix II[@R13], comprising the 3'-end of U6 snRNA and the 5'-end of U2 snRNA. U6 snRNA thereby tethers U2 and U5 snRNPs during spliceosome activation, when U4/U6 duplex unwinding and additional remodelling occurs. Importantly, the U2 snRNA nucleotides that form the active site U2/U6 helix I in B^act^ remain disordered in B complex and available for pairing with U6 snRNA during activation.

Interface B is transient and found only in a subgroup of cryo-EM particles (map B2) ([Fig. 3a, c](#F3){ref-type="fig"}, [Extended Data Figs 2](#F8){ref-type="fig"}, [5a](#F11){ref-type="fig"}, [Methods](#S6){ref-type="sec"}). This interface involves weak protein contacts between Cus1 (residues 328-353) and the RecA-1 lobe of the N-terminal helicase cassette (NHC) of Brr2 as well as between the Rse1 BPB and RecA-1 of NHC and RecA-2 of the C-terminal helicase cassette (CHC) of Brr2. The mobility of interface B may be important to allow SF3b and Brr2 to move independently during spliceosome activation.

B complex protein interactions {#S3}
==============================

Spp381, Prp38, and Snu23 are required for spliceosome activation and important for viability in yeast[@R5],[@R42],[@R43]. These proteins are B complex-specific in humans[@R44], whereas they associate with isolated U4/U6.U5 tri-snRNP in yeast[@R6],[@R43],[@R45], and are hereafter called B complex proteins. We obtained a reconstruction of the mobile B complex with a local resolution of 4.0-5.0 Å from a subset of cryo-EM particles by focused classification (map B7) ([Fig. 4](#F4){ref-type="fig"}, [Extended Data Figs 1g, f](#F7){ref-type="fig"}, [2](#F8){ref-type="fig"}, and [6](#F12){ref-type="fig"}). Previously, this density was either not interpreted[@R26] or tentatively attributed to part of Snu66 (ref.[@R27]). Prp38 scaffolds Spp381 and Snu23 (ref.[@R46]), and anchors these proteins at the Prp8 N-terminal domain (Prp8^N^), consistent with biochemical data[@R26],[@R31] ([Fig. 4](#F4){ref-type="fig"}). The Spp381 N-terminal region binds the winged helix (WH) domain of the Brr2 CHC, and continues between the Prp8 Jab1/MPN domain and the helix-loop-helix (HLH) domain of the Brr2 NHC with its long α-helix 2 ([Fig. 4](#F4){ref-type="fig"}). The Spp381 C-terminal region then binds along the globular Prp38 domain as its human counterpart[@R46] and extends towards Prp8^N^. This explains why deletion of the Spp381 N-terminal region impairs splicing, and why Spp381 can rescue the *prp38-1* temperature-sensitive mutation[@R5]. Snu23 contains a conserved ZnF domain that binds Prp38 and the major groove of the U6 snRNA ACAGAGA stem to stabilise it ([Fig. 4](#F4){ref-type="fig"}). The Snu23 N-terminus binds the RecA-2 lobe of the Brr2 NHC and reaches near the NHC RecA-1 ATP-binding pocket. Snu23 may thereby stabilise Brr2 on the U4 snRNA substrate and influence Brr2 helicase activity ([Extended Data Fig. 6f](#F12){ref-type="fig"}). Thus Spp381 and Snu23 together, held by Prp38, aid in positioning Brr2 to one side of tri-snRNP. Consistent with the structure, several Prp8 mutations that suppress the U4-cs1 mutant[@R47], which blocks U4/U6 unwinding, map near Prp8--B complex protein interfaces.

In B complex the 5'-stem loop of U6 snRNA binds the Prp8^N^ domain and the adjacent U6 nucleotides basepair with U5 loop 1. Consistent with this, U5 snRNA loop 1 nucleotides crosslink to a wide region surrounding the pre-mRNA 5'SS in B complex, suggesting that the 5'SS is in the vicinity of U5 loop 1 but does not basepair with it[@R48]. Pre-mRNA also does not crosslink to U5 loop 1 in the purified human B complex[@R2]. U6 snRNA continues past U5 loop 1 to form the ACAGAGA stem (map B7 and ref.[@R27]) and is stabilised by the Snu23 ZnF domain, the extended Prp38 N-terminus, and tri-snRNP proteins Dib1, Prp6, and Prp8 ([Fig. 4](#F4){ref-type="fig"}, [Extended Data Fig. 6g](#F12){ref-type="fig"}). Destabilisation of these interactions by mutations of the Prp38-Snu23 ZnF[@R5] interface and the Snu23 ZnF domain[@R43] causes growth defects in yeast. The base of the U6 snRNA ACAGAGA stem is further enclosed by the previously disordered Prp8 residues 2121-2140 (ref.[@R26],[@R27]) that form a β-hairpin, to which Snu23 adds a β-strand. A weak density (maps B2, B7) connects from the tip of the U6 ACAGAGA stem to the SF3b-bound intron ([Extended Data Fig. 6e](#F12){ref-type="fig"}), approximately 90 Å apart, and together with RNA crosslinking[@R2],[@R48] suggests that this is pre-mRNA near the 5'SS. Taken together, the structure indicates that the extensive interactions involving the B complex proteins stabilise Brr2 on U4 snRNA and the weak tethering of the putative 5'SS to U6 snRNA prior to spliceosome activation.

B complex assembly {#S4}
==================

Comparisons of yeast B complex and negative stain EM projections of human B complex[@R2],[@R32] reveal a conserved architecture, including the location of the Brr2 helicase (called 'stump' domain in ref.[@R2],[@R31]), suggesting that events before B complex formation may also be conserved. In the human system, an ATPase-deficient mutant of Prp28 accumulates the pre-B complex[@R2], where U1 snRNA remains paired to the 5'SS[@R3] ([Extended Data Fig. 7](#F13){ref-type="fig"}). In human U4/U6.U5 tri-snRNP Prp28 binds the Prp8^N^ and Prp8 Endonuclease (Prp8^EN^) domains and Sad1 and tethers the Brr2 helicase distant from its U4 snRNA substrate[@R25]. Importantly, the Prp28 binding site is altered and overlaps with that of the B complex proteins in yeast B complex ([Extended Data Fig. 6h](#F12){ref-type="fig"}). This suggests that Prp28 is released subsequent to disrupting the U1 snRNA--pre-mRNA interaction, to allow the recruitment of the B complex-specific proteins to the Prp8^N^ domain and binding and repositioning of the helicase Brr2 to its B complex location on U4 snRNA ([Extended Data Fig. 6h](#F12){ref-type="fig"}). The U6 ACAGAGA stem is subsequently stabilised by the B complex proteins to allow tethering of the 5'SS near the tip of the stem prior to activation, consistent with crosslinking[@R48]. Prp28 and Sad1 exist in both yeast and humans, suggesting that conversion from pre-B to B complexes is a conserved feature of splicing. We also note that the surprisingly large space between opposite ends of the concave B complex structure may accommodate the U1 snRNP during early spliceosome assembly ([Extended Data Fig. 7c](#F13){ref-type="fig"}) and allow for structural rearrangements during spliceosome activation.

Model of spliceosome activation {#S5}
===============================

Comparison of the yeast B complex structure presented here with the yeast B^act^ structure[@R20],[@R21] leads to a more detailed model for spliceosome activation ([Fig. 5](#F5){ref-type="fig"}, [6](#F6){ref-type="fig"}, [Extended Data Fig. 7d](#F13){ref-type="fig"}, [8](#F14){ref-type="fig"}). In B complex, the helicase Brr2 is positioned by the B complex proteins and engaged with the U4 snRNA substrate. The 3'-end of U6 snRNA is held by pairing with U2 snRNA, while the 5'-stem of U6 snRNA is anchored to the Prp8^N^ domain. Spliceosome activation is initiated by ATP-dependent translocation of Brr2 along U4 snRNA. Unwinding of the U4/U6 duplex exposes the central region of U6 snRNA, which may fold spontaneously to form the U6 snRNA internal stem loop. The disordered single-stranded region of U2 snRNA in B complex ([Fig. 3b](#F3){ref-type="fig"}) then pairs with U6 snRNA to form U2/U6 helix 1a and 1b (ref.[@R13]), followed by formation of the catalytic U2/U6 triplex to complete the catalytic RNA centre[@R49] ([Fig. 6](#F6){ref-type="fig"}). The loss of U4 snRNA and U4/U6 di-snRNP proteins together with formation of the catalytic centre may induce a large movement of the U2 snRNP towards the Prp8 Large (Prp8^L^) domain, and facilitate a new contact between the SF3b Rse1 BPB and Brr2, which also moves from its B complex location ([Fig. 6](#F6){ref-type="fig"}). The B complex proteins may detach from Brr2 in this new position, due to a steric clash with the Prp8^EN^ domain. This uncovers the binding site for B^act^-specific proteins Cwc24 and Cwc27 at the Prp8^N^ and Prp8^EN^ domains, which stabilise the new interaction network. Our model suggests that the folding energy of the catalytic RNA core alone could mediate several of the observed remodelling events ([Fig. 6](#F6){ref-type="fig"}) and promote the binding of stabilising B^act^, NTC, and NTR proteins.

Prior to activation, U6 snRNA binds Prp8^N^ with its 5'-stem, passes over U5 loop 1, and forms the U6 ACAGAGA stem, where it tethers the pre-mRNA near its 5'SS. U4/U6 unwinding together with the loss of U4/U6 di-snRNP and tri-snRNP-specific proteins, and destabilization of B complex proteins allow the U6 5'-stem to reposition to the opposite side of the complex ([Fig. 5](#F5){ref-type="fig"}), where NTR proteins Bud31, Ecm2, and Cwc2 anchor it onto Prp8^N^ in B^act^. These remodelling events free U5 loop 1 from U6 snRNA and together destabilise the U6 ACAGAGA stem. The tethered 5'-exon and 5'SS can now be recognized by the exposed U6 ACAGAGA box and U5 loop 1. The 5'-exon is then loaded in the newly created exon channel, formed by rotation of the U5 foot domain and association of Cwc21 and Cwc22 (ref.[@R18]) ([Extended Data Fig. 8](#F14){ref-type="fig"}). A loop of SF3a subunit Prp11 folds in B^act^ and together with Cwc24 shields the 5'SS from the active site, while the SF3b-bound branch helix is immobilized 50 Å away, ready for Prp2-mediated conversion to B\* and step I of splicing[@R18].

Activation in yeast, from B to B^act^ complex spliceosomes, involves the release of 24 proteins[@R9],[@R31] and the recruitment of 22 others ([Extended Data Fig. 8a](#F14){ref-type="fig"}) plus extensive rearrangements of the RNA network. Detailed structural knowledge of both B and B^act^ complexes now provides a framework to dissect the activation mechanism and to determine the precise order of molecular events leading to formation of the spliceosome active site.

Methods {#S6}
=======

Preparation and purification of B complex {#S7}
-----------------------------------------

To prepare B complex spliceosomes for structural study, we grew yeast *Saccharomyces cerevisiae* containing a TAPS affinity tag on Brr2 (ref.[@R51]) in a 120 L fermenter. Splicing extract was prepared using the liquid nitrogen method essentially as described[@R52], with an additional 18 h dialysis against buffer A (20 mM HEPES (pH 7.9), 50 mM KCl, 20% glycerol, 0.2 mM EDTA, 0.5 mM DTT), to deplete ATP. *UBC4* pre-mRNA[@R53] containing two MS2 stem loops at the 5'-end was made by *in vitro* transcription. The RNA product was subsequently labelled with fluorescein[@R54] at its 3'-end to monitor complex purification. *In vitro* splicing reactions were assembled from pre-mRNA substrate pre-bound to MS2-MBP fusion protein as described[@R55]. Splicing reactions contained 50 µM ATP to stall splicing at the B complex stage as described[@R9],[@R34], and proceeded for 50 min at 23 ºC. The reaction mixture was centrifuged through a 40% glycerol cushion in buffer B (20 mM HEPES (pH 7.9), 50 mM KCl, 1% glycerol, 0.2 mM EDTA, 1 mM DTT, 0.04% NP-40). The cushion was collected, diluted with buffer B, and applied to amylose resin (NEB) pre-washed with buffer C (20 mM HEPES (pH 7.9), 75 mM KCl, 5% glycerol, 0.2 mM EDTA, 1 mM DTT, 0.03% NP-40). After 12 h incubation at 4ºC, the resin was washed with buffer C and eluted in buffer C containing 50 mM KCl and 12 mM Maltose. Fractions containing spliceosomes were pooled and applied to Strep-Tactin resin (GE Healthcare), pre-washed with buffer C, and incubated for 4 h at 4 ºC. The resin was washed with buffer C, and the sample was eluted with buffer D (20 mM HEPES (pH 7.9), 50 mM KCl, 0.2 mM EDTA, 1 mM DTT, 2.5 mM desthiobiotin). Fractions containing spliceosomes were pooled and crosslinked using 1 mM BS3 (Sigma) on ice for 1 h, and subsequently quenched with 50 mM Ammonium bicarbonate. The sample was concentrated to \~1.5 mg mL^-1^ and immediately used for EM sample preparation. The isolated complexes contained U2, U4, U5, U6 snRNA and pre-mRNA, and all proteins previously assigned to pre-catalytic spliceosomes[@R9],[@R31]. The U1 snRNP was identified in sub-stoichiometric amounts, consistent with its destabilization in B complex[@R2],[@R31] ([Extended Data Fig. 1a, b](#F7){ref-type="fig"}).

To confirm that purified B complex spliceosomes were functional, we carried out an *in vitro* splicing assay. B complex was prepared as for EM studies using labelled *UBC4* pre-mRNA, but was not crosslinked, and was flash-frozen in liquid nitrogen and stored at -80 ºC until further use. *In vitro* splicing was carried out in the presence of 2 mM ATP and unlabelled 60 nM pre-mRNA competitor, inhibiting *de novo* spliceosome assembly. Purified B complex was incubated with nuclear extract for 10 min before adding ATP, and product formation was visualized after 50 min of splicing at 23 ºC on a denaturing 18% TBE gel with a Typhoon scanner (GE Healthcare) ([Extended Data Fig. 1c](#F7){ref-type="fig"}).

Electron microscopy {#S8}
-------------------

B complex spliceosomes were studied by negative stain EM. Copper grids (Quantifoil) were coated with a \~10 nm homemade carbon film and glow-discharged 20 s before deposition of 3.5 µL sample (0.15 mg mL^-1^). The sample was incubated for 1 min and grids were blotted with three 3.5 µL drops of distilled water. The sample was stained in a 3.5 µL drop of saturated uranyl formate solution for 1 min, and blotted until dry. 409 images were recorded using a FEI Spirit microscope operated at 120 kV and a 2k×2k CCD camera with a defocus of approximately 1.5 µm and a nominal magnification of 26,000 (3.84 Å pixel^-1^).

For cryo-EM analysis the sample was applied to R1.2/1.3 holey carbon grids (Quantifoil) and coated with a 5--7 nm homemade carbon film. Grids were glow-discharged for 15 s before deposition of 3 µL sample (\~1.5 mg mL^-1^), and subsequently incubated for 2--3.5 s before blotting and vitrification by plunging into liquid ethane with a Vitrobot Mark III (FEI) operated at 4 °C and 100% humidity. Cryo-EM data was acquired on a FEI Titan Krios operated in EFTEM mode at 300 keV, equipped with a K2 Summit direct detector (Gatan) and a GIF Quantum energy filter (slit width of 20 eV, Gatan). Data acquisition was carried out with Digital Micrograph (Gatan) to record 5,115 movies with a defocus range of --0.35 µm to --5.3 µm at a nominal magnification of 81,000 (1.43 Å pixel^--1^). The camera was operated in 'super-resolution' mode (0.715 Å pixel^--1^) with a total exposure time of 16 s fractionated into 20 frames, a dose rate of \~1.25 e^−^ pixel^--1^ s^--1^, and a total dose of 56 e^−^Å^−2^ per movie. Movies were binned once and aligned using MOTIONCORR[@R56].

Image processing {#S9}
----------------

For single particles analysis CTF parameters were estimated using CTFFIND4 (ref.[@R57]) and CTF correction and subsequent image processing were carried out using RELION 2.0 beta[@R58], unless otherwise noted. Resolution is reported based on the gold-standard Fourier shell correlation (FSC) (0.143 criterion) as described[@R59] and temperature factors were determined and applied automatically in RELION[@R58]. For negative stain analysis 12,229 particles were selected semi-automatically using e2boxer.py from EMAN2[@R60], extracted using a 176[@R2] pixel box and pre-processed to normalize the images. The negative stain map of human BΔU1 (ref.[@R32]) (EMD-1066) was used as an initial reference for three-dimensional (3D) refinement of the 12,229 particles set. A single round of 3D classification revealed a B complex density from 3,707 particles ([Extended Data Fig. 3](#F9){ref-type="fig"}) that was refined to an estimated resolution of 50 Å ([Extended Data Fig. 3b](#F9){ref-type="fig"}). This density was low-pass filtered to 60 Å and used for processing of cryo-EM data.

For cryo-EM analysis an initial set of 7,208 particles were selected semi-automatically using e2boxer.py[@R60], and extracted with a 480[@R2] pixel box and pre-processed to normalize the images. Reference-free two-dimensional (2D) class averages were calculated and filtered to 30 Å resolution and used for automated picking in RELION[@R61] of all micrographs. The resulting particles were screened manually and by reference-free 2D classification, yielding 496,581 particles for subsequent processing. A 3D reconstruction of all particles was calculated to an overall resolution of 4 Å, and subjected to particle polishing in RELION[@R58], improving the resolution to 3.7 Å.

Hierarchical 3D classification was carried out without image alignment to reduce computational costs and identify homogenous particle groups ([Extended Data Fig. 2](#F8){ref-type="fig"}). Soft masks enveloping complete B complex or smaller regions were generated using the volume eraser in UCSF Chimera[@R62] and RELION[@R58]. This included masks for tri-snRNP (excluding the helicase domain), B complex proteins, U2 snRNP SF3b and U2 3' domain/SF3a subcomplexes. Each resultant class was refined using the 3D auto-refine procedure against the respective particles within that class with a soft reference mask in the shape of the feature of interest, yielding B1-7 reconstructions ([Extended Data Figs 1e](#F7){ref-type="fig"}, [2](#F8){ref-type="fig"}, and [3c, d](#F9){ref-type="fig"}). To improve the resolution of regions with weak density, we used focused refinements (B4, B5, B7) together with signal subtraction (B1, B3, B6) as described[@R63]. The B1 reconstruction (improved SF3b density) was calculated in a focused refinement from 254,095 particles from which the tri-snRNP signal was subtracted[@R63], and was determined to a resolution of 3.9 Å with a temperature factor of -125. The B2 reconstruction was determined from 9,559 particles to a resolution of 7.2 Å with a temperature factor of -170, and was used to determine the relative positions of U2 snRNP and tri-snRNP for the complete B complex model (see [Structural Modelling](#S10){ref-type="sec"}). The B3 reconstruction (improved U2 3' domain/SF3a densities) was calculated in a focused refinement from 79,166 particles from which the U2 snRNP SF3b and tri-snRNP signal was subtracted[@R63], and was determined to a resolution of 17.2 Å with a temperature factor of -200. The low resolution of the B3 density is likely due to flexibility of the U2 3' domain relative to SF3a. The B4 reconstruction (improved tri-snRNP body density) was calculated in a focused refinement from 327,490 particles to a resolution of 3.6 Å with a temperature factor of -105. The B5 reconstruction (improved tri-snRNP foot domain density) was calculated in a focused refinement from 327,490 particles to a resolution of 3.8 Å with a temperature factor of -127. The B6 reconstruction (improved helicase density) was calculated in a focused refinement from 327,490 particles from which the tri-snRNP signal, excluding the helicase domain, was subtracted[@R63], and was determined to a resolution of 4.3 Å with a temperature factor of -140. The B7 reconstruction (improved B complex protein density) was calculated in a focused refinement from 62,406 particles to a resolution of 4.0 Å with a temperature factor of -80. Local resolution estimates were determined using ResMap[@R64] ([Extended Data Fig. 3e, f](#F9){ref-type="fig"}).

Structural Modelling {#S10}
--------------------

A composite model of B complex was obtained using B1 to B7 densities ([Extended Data Fig. 1f, g](#F7){ref-type="fig"}, [9](#F15){ref-type="fig"}, [Extended Data Table 1](#T1){ref-type="table"}). Model building was carried out in COOT[@R65]. Coordinates were refined in real space using phenix.real_space_refine in PHENIX[@R66] into the respective sharpened density, applying secondary structure, rotamer, nucleic acid, and metal coordination restraints, unless otherwise noted ([Extended Data Fig. 9](#F15){ref-type="fig"}). The B^act^ SF3b and Prp11 ZnF cryo-EM model[@R21] (PDB 5GM6) was fitted into the B1 density and adjusted. We additionally modelled the conserved Prp9 ZnF2, Prp9 C-terminus (residues 503-528), Cus1 N- and C-terminal regions, U2 snRNA stem IIb, and re-assigned Hsh49 RRM2. The Cus1(residues 290-368)-Hsh49 RRM1 crystal structure[@R28] was fitted into the B1 density and adjusted. The pre-mRNA sequence was changed to that of *UBC4* and an altered pre-mRNA path downstream from the branch point adenosine could be determined ([Extended Data Fig. 8e](#F14){ref-type="fig"}). Further, the crystal structure of the LSm ring[@R67] (PDB ID 4M7A) could be fitted in a unique orientation in the B1 density and the putative Prp3 N-terminal region (residues 35-71) as well as a poly-alanine model of Prp3 helix α3, bridging SF3b to the LSm ring, were modelled. The amino acid register for Prp3 residues 35-138 is uncertain. A homology model of the yeast Sm ring was generated based on the human Sm ring[@R68] (PDB ID 4WZJ) using MODELLER[@R69] and was fitted into B5 and B6 maps for U5 and U4 snRNPs, respectively, and adjusted. The cryo-EM structure of the U2 3' domain from C complex[@R18], where the Sm ring was replaced with the adjusted MODELLER[@R69] model, and the SF3a crystal structure[@R29], where selenomethionine residues were changed to the original protein sequence in COOT[@R65], were fitted automatically into the B3 density using a global 6D search in Situs[@R70]. The U2 3' domain/SF3a complex was positioned relative to SF3b (B1 density) by fitting into the reconstruction from round 5 class 6 ([Extended Data Fig. 2](#F8){ref-type="fig"}). This yielded a model for the complete U2 snRNP as well as its interaction with Prp3 and the nearby LSm ring. Previous cryo-EM models of the yeast tri-snRNP[@R26],[@R27] (PDB ID 3JCM and 5GAN) were fitted into B4, B5, and B6 cryo-EM densities, and were manually adjusted and extended in COOT. The B4 density was used in particular to improve models for Prp3, Prp4, Prp6, and Prp31. A Prp6 helix (residues 64-80) was assigned based on weak density connectivity. Snu66 (residues 148-236) and two peptides of unknown polarity, which bind Prp6 and the Prp8 switch loop, were built as well. The U6 5'-stem and the U6 nucleotides that bind U5 snRNA loop 1 were located in the B4 map, as in an earlier study[@R27]. The U5 snRNA variable stem-loop II, stem III, and stem IV ([Extended Data Fig. 7a](#F13){ref-type="fig"}) were predicted by RNAfold[@R71] and RNAComposer[@R72], and fitted into the B5 density and adjusted. Using the B6 density models for Brr2, U4 snRNA, and the Sm ring were adjusted and the register of Snu66 bound to Brr2 was revised (residues 297-323 and 343-364), consistent with protein crosslinking[@R26]. Additionally, the Spp381 N-terminal region (residues 98-151) was identified based on density connectivity to the Spp381 C-terminus ([Extended Data Fig. 6a](#F12){ref-type="fig"}) and protein crosslinking[@R26] and was modelled as poly-alanine. The Snu23 helix α1 was placed as a poly-alanine model into the B6 density, based on connectivity to the Snu23 ZnF. To model the globular domain of the B complex proteins Spp381, Snu23 and Prp38, we first generated a homology model based on the *Chaetomium thermophilum* Prp38-Snu23 (residues 137-157)-MFAP1 (yeast Spp381; residues 217-296) heterotrimer[@R46] (PDB ID 5F5V) using MODELLER[@R69]. The homology model was fitted into the B7 density and adjusted and extended in COOT[@R65]. Spp381 helices α3 and α4 were modelled as poly-alanine into weak density (B7) based on homology to the *Chaetomium thermophilum* structure[@R46]. Snu23 ZnF and Prp38 N-terminal regions and the previously disordered Prp8 residues 2121-2148 (ref.[@R26],[@R27]), connecting RNase H and Jab1/MPN domains, were built into the B7 density. The complete U6 ACAGAGA stem could be modelled in the B7 map, together with a short stretch of density that we assigned to pre-mRNA. This density connects at low threshold to the intron bound by the U2 snRNP SF3b subcomplex, suggesting it is pre-mRNA ([Extended Data Fig. 6](#F12){ref-type="fig"}). This density could not be assigned to another part of B complex as surrounding protein and RNA parts are accounted for. The register of pre-mRNA at the U6 ACAGAGA stem is unknown, and was modelled here based on complementarity with *UBC4* pre-mRNA upstream and nearest to the 5'-exon, consistent with RNA crosslinking[@R48]. To generate a model for tri-snRNP, we combined models refined into B4, B5, B6, and B7 densities, and placed them together into the B7 map. To generate the complete B complex model, we used a reconstruction of B complex with a defined position of the U2 snRNP SF3b complex relative to tri-snRNP (round 3 class 8, [Extended Data Fig. 2](#F8){ref-type="fig"}), to reveal their transient contact at interface B ([Fig. 3a, c](#F3){ref-type="fig"}) and model the complete U2 snRNP on tri-snRNP. The U2 snRNP is flexibly linked to tri-snRNP, and adopts a continuum of conformations (round 4, [Extended Data Fig. 2](#F8){ref-type="fig"}). The Prp3 helix α4, modelled as an ideal α-helix as poly-alanine, and U2/U6 helix II, modelled as an idealized double-stranded RNA helix, were rigid-body fitted into the B2 density. To visualize the transition from B to B^act^ complex spliceosomes, we revised the SF3b model in the B^act^ structure[@R21] (PDB ID 5GM6) in the corresponding density (EMD-9524) and modelled the U2 3' domain/SF3a subcomplexes based on another B^act^ cryo-EM map[@R20] (EMD-4099) that was low-pass filtered to 30 Å resolution. The final B complex structure comprises 52 proteins, 4 snRNAs, and the pre-mRNA substrate ([Fig. 1](#F1){ref-type="fig"}, [Extended Data Table 1](#T1){ref-type="table"}). Figures were generated with PyMol (<http://www.pymol.org>) and UCSF Chimera[@R62].

Extended Data {#S11}
=============

![Biochemical characterization and cryo-EM of the B complex spliceosome.\
**a**, Protein analysis of purified B complex (SDS-PAGE stained with Coomassie blue). U1 snRNP components and U1 snRNA are sub-stoichiometric (see **b**), consistent with U1 snRNP destabilization in B complex[@R2],[@R31]. For gel source data see [Supplementary Figure 1a](#SD2){ref-type="supplementary-material"}. **b**, RNA analysis of purified B complex (denaturing 9 % polyacrylamide TBE gel stained with Toluidine blue). For gel source data see [Supplementary Figure 1b](#SD2){ref-type="supplementary-material"}. **c**, Purified B complex is active in an *in vitro* splicing assay. Splicing reactions were carried out in yeast extract in absence (Lanes 1 and 2) or presence of 60 nM competitor pre-mRNA (Lane 3), prohibiting the assembly of new spliceosomes. B complex was assembled on labelled pre-mRNA and purified (see [Methods](#S6){ref-type="sec"}), and added to yeast extract for 10 min together with 60 nM unlabelled competitor pre-mRNA, before addition of ATP to initiate the reaction (Lanes 4 and 5). Splicing reactions contained 2 mM ATP (Lanes 1-5). The asterisk marks a degradation product. For gel source data see [Supplementary Figure 1c](#SD2){ref-type="supplementary-material"}. **d**, Cryo-EM micrograph of B complex. Scale bar, 200 nm. **e**, Representative 2D class averages of B complex reveal flexibility of peripheral regions relative to the tri-snRNP body. **f**, Composite cryo-EM density of B complex shown in two orthogonal views. Colours indicate the respective cryo-EM densities used for modelling (B1, green; B2, yellow; B3, light green; B4, grey; B5, blue; B6, light blue; B7, magenta). The sharpened densities are shown and are aligned using overlapping regions (see [Extended Data Fig. 2](#F8){ref-type="fig"}). The percentage of particles from the full set of 496,581 that contribute to the respective density are indicated together with the overall resolution (see [Extended Data Fig. 9](#F15){ref-type="fig"}). **g**, Composite cryo-EM density of B complex superimposed on a ribbon model of the B complex structure, coloured as in [Fig. 1](#F1){ref-type="fig"}. B complex, excluding the U1 snRNP, has a molecular weight of 2.5 MDa of which we modelled 1.8 MDa.](emss-72630-f007){#F7}

![Three-dimensional classification of cryo-EM data.\
Three-dimensional image classification of the cryo-EM data set using the B complex negative stain reconstruction ([Methods](#S6){ref-type="sec"}; [Extended Data Fig. 3b](#F9){ref-type="fig"}) as the initial reference model. The percentage of single particles contributing to each class is provided. To help visualize structural differences, 3D reconstructions of B complex are coloured according to mobile regions: SF3b (green), U2 3' domain/SF3a (light green), helicase (cyan), body (grey), foot (navy blue), and B complex proteins (magenta). For each classification round the type of mask and use of signal subtraction is indicated. The type of mask, overall resolution, and use of signal subtraction is also indicated for each 3D refinement subsequent to classification. For additional details see the [Methods](#S6){ref-type="sec"} and [Extended Data Fig. 9](#F15){ref-type="fig"}.](emss-72630-f008){#F8}

![Negative stain and cryo-EM reconstructions of B complex.\
**a**, Three-dimensional image classification of negative stain EM data. 12,296 particles were refined using the negative stain reconstruction of the human BΔU1-complex[@R32] (EMD-1066) as the initial reference, and were subsequently classified. Class 2 contained most features and was used for 3D refinement. The percentage of single particles contributing to each class is provided. **b**, Two orthogonal views of the yeast B complex negative stain reconstruction used as the initial reference for processing of the cryo-EM data set. **c**, Gold-standard Fourier shell correlation (FSC = 0.143) of the respective B1, B2, B3, B4, B5, B6, and B7 cryo-EM single particle reconstructions. **d**, Orientation distribution plot of all particles that contribute to the respective B1, B2, B3, B4, B5, B6, and B7 cryo-EM single particle reconstructions. **e**, The composite B complex cryo-EM density (maps B1-7) is shown in two orthogonal views and coloured by local resolution, as determined by ResMap[@R64]. Compare [Extended Data Fig. 1f](#F7){ref-type="fig"}. **f**, A central slice through the composite B complex cryo-EM density (maps B1-7) is shown in two orthogonal views and coloured by local resolution, as determined by ResMap[@R64].](emss-72630-f009){#F9}

![Details of the U2 snRNP.\
**a**, Multiple conformations of the U2 snRNP 3' domain/SF3a subcomplexes relative to SF3b indicate flexibility. This apparent mobility may be important to form A complex, consistent with dynamic contacts of the U2 snRNA 5'-end with SF3a60 (human Prp9) and SF3b49 (human Hsh49) in the isolated U2 snRNP[@R40] that differ from U2 snRNP protein--snRNA interactions observed in the yeast B complex structure. Surface representations of U2 3' domain (light green), SF3a (light yellow), and SF3b (dark green) are shown. U2 3' domain/SF3a are positioned according to 3D classes 1, 6, and 7 from round 5 (compare [Extended Data Fig. 2](#F8){ref-type="fig"}). A cartoon summarizes the movements. **b**, Representative regions of the sharpened SF3b-containing density (B1) at 3.9 Å resolution are superimposed on the refined coordinate model. The density shows side-chain features for a loop in Cus1, a β-strand in Rse1, an α-helix in Hsh155, and separation of RNA nucleotides in the U2--pre-mRNA branch helix. Colours as in [Fig. 2](#F2){ref-type="fig"}. **c**, Cryo-EM densities for SF3a are superimposed on the B complex coordinate model. The crystal structure of the Y-shaped core of SF3a[@R29] is superimposed on the B3 density. Prp11 ZnF, Prp9 ZnF2 and the Prp9 C-terminus are superimposed on the B1 density. Structural elements of SF3a, including the Prp9 wedge helix, and disordered regions are indicated. For cryo-EM density nomenclature see [Extended Data Fig. 1f](#F7){ref-type="fig"}. Colours as in [Fig. 2](#F2){ref-type="fig"}.](emss-72630-f010){#F10}

![Flexibility of the U2 snRNP relative to tri-snRNP.\
**a**, Multiple positions of the U2 snRNP relative to tri-snRNP. Representative classes are shown (class 1, 6, and 8 from round 3, see [Extended Data Fig. 2](#F8){ref-type="fig"}) that reside along a continuum of conformations (compare [Extended Data Fig. 1e](#F7){ref-type="fig"}). The U2 snRNP moves together with the U6 LSm ring, which is anchored via the putative Prp3 N-terminus. A cartoon summarizes the movements in two orthogonal views. The location of the U2 snRNP has an apparent effect on the strength of the putative pre-mRNA 5'-exon cryo-EM density (compare [Extended Data Fig. 6e](#F12){ref-type="fig"}). When the U2 snRNP is positioned away from the U6 ACAGAGA stem, the pre-mRNA density is weaker than when the U2 snRNP is positioned closer. This suggests how Brr2 helicase activity may carry out a kinetic proofreading of the pre-mRNA 5'-exon--U6 snRNA interaction: When the U2 snRNP is close to tri-snRNP activation may occur normally (productive activation). However, when the U2 snRNP is positioned further away and the 5'-exon is not tethered, Brr2 activity may instead lead to dissociation of the U2 snRNP from tri-snRNP (non-productive activation)[@R12]. **b**, The Prp3 model is superimposed on B1 (putative N-terminal region), B2 (helix α4) and B4 (C-terminal region) cryo-EM densities. The Prp3 ferredoxin-like fold (FER) and secondary structure elements are labelled. The black triangle indicates the region of Prp3 helix α4 that bends with different U2 snRNP positions (see **a**). For cryo-EM density nomenclature see [Extended Data Fig. 1f](#F7){ref-type="fig"}.](emss-72630-f011){#F11}

![Details of B-specific proteins and U6 snRNA.\
**a**, Fit of the Spp381 model to B6 (helix α1-α2) and B7 (helix α3-α4) cryo-EM densities. Helix α4 was modelled into weak density (B7) based on homology to the human and *Chaetomium thermophilum* crystal structure[@R46]. For cryo-EM density nomenclature see [Extended Data Fig. 1f](#F7){ref-type="fig"}. **b**, Fit of the Prp38 model to the B7 cryo-EM density. Helix α5 is shown below, revealing side-chain features in the density. **c**, Fit of the Snu23 model to B6 (helix α1) and B7 (remainder of Snu23) cryo-EM densities. Helix α2 is shown below, revealing side-chain features in the density. **d**, Composite cryo-EM density and fit of the U6 snRNA model. The B1, B2, B4, B5, and B7 densities are shown without (left) and with the U6 snRNA model superimposed (right). U6 elements and the site of interaction with U5 snRNA loop 1 are indicated. **e**, A weak density for pre-mRNA connects from the U6 snRNA ACAGAGA stem to the U2 SF3b-bound intron. The connecting density (map B2) is shown at intermediate (gray, threshold of 0.023) and low thresholds (light blue, threshold of 0.0173). The U6 snRNA densities are shown as in panel d. The register of pre-mRNA near the U6 ACAGAGA stem is uncertain and was tentatively modelled based on complementarity with *UBC4* pre-mRNA upstream and nearest to the 5'-exon, consistent with RNA crosslinking[@R48]. According to this register \~40 pre-mRNA nucleotides separate U6- and SF3b-bound regions. The lower right panel shows the fit of the pre-mRNA--U6 snRNA ACAGAGA stem loop model to the unsharpened B7 density. For cryo-EM density nomenclature see [Extended Data Fig. 1f](#F7){ref-type="fig"}. **f**, Snu23 binds near the nucleotide-binding pocket of the N-terminal Brr2 helicase cassette, where it may influence Brr2 activity. Brr2 (pale cyan) and Snu23 (violet) models are superimposed on the B6 cryo-EM density, coloured as the underlying proteins. The RecA-1 and RecA-2 lobes of the N-terminal Brr2 helicase cassette are labelled, and an ADP nucleotide was modelled by aligning the N-terminal helicase cassette of human Brr2 bound to ADP (ref.[@R73]) (PDB ID 4KIT) on the equivalent yeast Brr2 residues. The path of the Snu23 N-terminus cryo-EM density is indicated, and is near to the Brr2 nucleotide-binding pocket. **g**, The U6 ACAGAGA stem is chaperoned by Dib1, Prp6, Prp8, and B complex proteins. Stabilization of the U6 ACAGAGA stem may facilitate tethering of pre-mRNA at its tip, whereas the U6 ACAGAGA box is buried in the stem. Surface models of Snu23 ZnF, Prp38 N-terminus, Prp6 N-terminus, Dib1, Prp8^L^ and Prp8^N^ domains, and Brr2 are shown and reveal a network of protein-RNA contacts to maintain the U6 stem. **h**, Comparison of human tri-snRNP[@R25] (PDB ID 3JCR) and yeast B complex (this study) reveals that the Prp8^N^ and Prp8^EN^ domains serve as a platform for mutually exclusive binding of Prp28 and B complex proteins. Their Prp8^N^ binding sites overlap and the altered location of the Prp8^EN^ domain between the two complexes provides additional interfaces for either Prp28 or B complex proteins to bind. Movements compared to B complex in Brr2 and U4/U6 di-snRNP are indicated with arrows, and may occur after A complex association. The U2 snRNP is shown in grey to highlight tri-snRNP components, which are coloured as in [Fig. 1](#F1){ref-type="fig"}. Comparison with B^act^ and C\* structures[@R20]--[@R24] further suggests that Prp8^N^ and Prp8^EN^ domains serve as a general platform for step-specific splicing factors during the splicing cycle.](emss-72630-f012){#F12}

![U5 snRNA model, location of the U1 snRNP, and RNA secondary structure diagrams.\
**a**, An improved model for U5 snRNA. A secondary structure diagram (left) and refined coordinate model (right) are shown, and the newly determined Variable Stem Loop II, Stem III, and Stem IV are labelled together with known U5 snRNA elements. The long form of U5 snRNA is shown, where the short form ends with nucleotide 179. The grey boxes indicate regions not included in the model. Lines indicate Watson-Crick base-pairs, and dots indicate G-U wobble base-pairs. The U5 snRNA model was prepared by M. Wilkinson. **b**, Putative model of the RNA interaction network in the pre-B complex. The RNA network is unchanged compared to B complex, except for the interaction of the pre-mRNA 5'-exon with U1 snRNA[@R74]. Only loop 1 of U5 snRNA is shown. Lines indicate Watson-Crick, dots G-U wobble, stars non-canonical, and dotted lines putative nucleotide interactions. **c**, Putative location of the U1 snRNP. To gain insights into U1 snRNP location relative to U2 snRNP and tri-snRNP, we combined genetic, biochemical, and structural observations. The U1 snRNP likely binds between the human SF3a subunit SF3A1 (yeast Prp21)[@R75], the Prp28 binding site[@R25], Brr2[@R76], and the U6 ACAGAGA stem. In B complex, the U1 snRNP may be destabilised due to a steric clash with Brr2, that is likely to be repositioned compared to the pre-B complex as in the human tri-snRNP structure[@R25]. In humans, the U1 snRNP may be further destabilised by a loss of A complex-specific proteins[@R2]. Brr2 repositioning may therefore serve as a checkpoint to signal the release of U1 snRNA from pre-mRNA. **d**, RNA secondary structure diagrams of regions modelled in B and B^act^ complex spliceosomes, using *UBC4* pre-mRNA. The pre-mRNA substrate in B^act^ (ref. [@R21]) is a mixture of cellular pre-mRNAs and its sequence is replaced by that of *UBC4*. The consensus nucleotides at the 5'SS and branch point sequence in yeast are shown in bold. Only loop 1 of U5 snRNA is shown. Lines indicate Watson-Crick, dots G-U wobble, stars non-canonical, and dotted lines putative nucleotide interactions. Highlighted are the branch point adenosine (BP), pre-mRNA 5'- and 3'-exons, and the U6 ACAGAGA box.](emss-72630-f013){#F13}

![Compositional and conformational changes during spliceosome activation.\
**a**, List of RNA and protein components in B and B^act^ complex spliceosomes. During spliceosome activation 22 proteins join the spliceosome, whereas 24 proteins (or 41 including the U1 snRNP) and U1 and U4 snRNA are released. The U1 snRNP is indicated with a dashed line due to its substoichiometric binding in B complex. RES complex proteins were not modelled in B complex, however, weak density is visible at the same binding site as in B^act^ (ref.[@R20],[@R21]), consistent with mass spectrometry (ref.[@R9] and data not shown). **b**, Movement of the Prp8 RNase H (Prp8^RH^) domain between B and B^act^ complex spliceosomes. In B complex (left) regions of Prp3, Prp6, and Snu66 (residues 148-236) contact the Prp8^RH^ domain and its β-hairpin (red). The Prp8 large domain (Prp8^L^) is shown as a surface and subunits are coloured as in [Fig. 1](#F1){ref-type="fig"}. An arrow indicates the movement of the Prp8^RH^ domain to its B^act^ position[@R21] (right; PDB ID 5GM6), where it is stabilised by Hsh155, Prp45 (yellow), and Cwc22 (dark violet). B and B^act^ models were aligned on the Prp8^L^ domain. **c**, Movements of the Prp8 switch loop and N-terminal domain between B and B^act^ complex spliceosomes. In B complex (left) an unassigned peptide (orange) binds the Prp8 switch loop, stabilizing it on the Prp8^L^ domain. The Prp8 N-terminal domain (Prp8^N^) is shown as a surface (magenta) and binds the U6 snRNA 5'-stem. The Prp8 Endonuclease (Prp8^EN^) domain is labelled. Arrows indicate the movements required to transition to B^act^ (PDB ID 5GM6). The unassigned peptide is released in B^act^ (right) and Cwc21 (yellow) and Cwc22 (dark violet) bind in its stead to stabilise the new position of Prp8 switch loop and the loaded pre-RNA 5'-exon (light orange) in the exon channel. The re-positioned Prp8^N^ domain completes this channel. B and B^act^ models were aligned on the Prp8^L^ domain. **d**, Movements of U2 3' domain/SF3a subcomplexes between B and B^act^ complex spliceosomes. In B complex (left) the U2 3' domain/SF3a subcomplexes are flexibly linked to SF3b and assume several positions relative to SF3b (compare [Extended Data Fig. 4a](#F10){ref-type="fig"}). For comparison to B^act^, the model for U2 3' domain/SF3a (light green/grey) was rigid-body fitted into a low-pass filtered cryo-EM density of yeast B^act^ (ref.[@R20]) (EMD-4099). This indicated that in B^act^ (right) U2 3' domain/SF3a are repositioned due to binding of NTC proteins Syf1 and Clf1 (yellow arch), to avoid a steric clash. The NTC subunits Syf1 and Clf1 may thus be positioned in B^act^ to bind the U2 3' domain after the release of SF3a, during conversion to B\* ([Extended Data Fig. 8d](#F14){ref-type="fig"}). This repositioning is distinct from U2 3' domain/SF3a conformations that are sampled in B complex. B and B^act^ models of the U2 snRNP were aligned on SF3b subunit Rse1. **e**, Movements of SF3b subunit Hsh155 and pre-mRNA between B and B^act^ complex spliceosomes. B and B^act^ (PDB ID 5GM6) models were aligned on Hsh155, revealing small conformational changes in Hsh155 HEAT repeats, possibly due to extended interaction of Hsh155 with Prp8, Snu17, and Prp45 (grey arches) in B^act^. The U2--pre-mRNA branch helix is bound in the same manner in B and B^act^ complex spliceosomes. However, nucleotides downstream of the branch point (BP, magenta) are bound differently, possibly due to movements in Hsh155. **f**, Structural differences between B and B^act^ complex spliceosomes suggest a model for activation. The ATP-dependent helicase Brr2 is positioned in B complex (panel 1) and unwinds the U4/U6 duplex to release U4 snRNA and U4/U6 and B complex proteins (panel 2). Their removal enables movements in Brr2, U2 and U5 snRNPs, and U6 snRNA to facilitate the loading of pre-mRNA, and formation of the U2/U6 catalytic centre (panel 3). This intermediate is subsequently stabilised by NTC, NTR, splicing factors and B^act^ complex proteins to form B^act^ (ref.[@R21]) (panel 4; PDB ID 5GM6). U5 snRNP (blue; U5 snRNA, light grey), U4/U6 di-snRNP (light yellow; U4 snRNA, yellow; U6 snRNA, red), U2 snRNP (U2 3' domain, light green; SF3a, olive; SF3b, dark green), B complex proteins (shades of magenta), NTC, NTR and splicing factors (light yellow), and B^act^ complex proteins (shades of salmon) are indicated. The B^act^ position of U2 snRNP 3' domain/SF3a was modelled as in [Fig. 5](#F5){ref-type="fig"}. B and B^act^ spliceosomes were aligned on their Prp8^L^ domain. Spliceosome activation intermediates are modelled.](emss-72630-f014){#F14}

![Data collection, refinement statistics, and structure validation.\
**a**, Cryo-EM data collection and refinement statistics of the B complex structure. Different regions of the composite B complex structure were refined into B1, B4, B5, B6, and B7 maps as described (see [Methods](#S6){ref-type="sec"}). **b**, FSC between local cryo-EM map regions and corresponding regions of the refined coordinate models. Note that the FSC curve for the B-specific proteins correlates with the local resolution in this subregion of the B7 density (4.0-5Å, [Extended Data Fig. 3d](#F9){ref-type="fig"}), below the nominal resolution (4.0 Å).](emss-72630-f015){#F15}

###### Summary of components modelled into B complex cryo-EM densities

  Proteins and RNA included in the model                                                                                                                                                                                                                                                                         
  ---------------------------------------- --------------- ------------ ---------------------- ---------------------------------------------------------------------------------- --------------------------------------- ------------------------------- ------------------------------- ---------------------- ------------------------
  U5 snRNP                                 Prp8            N-terminal   1-870                  101.7                                                                              128-870                                 5GAN, 3JCM                      Docked and rebuilt              A                      U5-220K/*Spp42*
  Large                                    871-1827        111.5        871-1827               5GAN, 3JCM                                                                         Docked and rebuilt                                                                                                             
  RNaseH                                   1828-2085       29.5         1828-2085              5GAN, 3JCM                                                                         Docked and rebuilt                                                                                                             
  Jab1/MPN                                 2086-2413       36.8         2086-2109; 2121-2401   5GAN                                                                               Docked                                                                                                                         
                                                                                                                                                                                                                                                                                                                 
  Brr2                                                        2,163     246.2                  447-1712; 1716-1825; 1841-2163                                                     5GAN                                    Docked and rebuilt              B                               U5-200K/*Brr2*         
                                                                                                                                                                                                                                                                                                                 
  Snu114                                                     1008         114.0                105-517; 531-693; 706-725; 742-770; 774-979; 986-1005                              5GAN, 3JCM                              Docked and rebuilt              C                               U5-116K/*Cwf10*        
                                                                                                                                                                                                                                                                                                                 
  Dib1                                                      143         16.8                   2-143                                                                              5GAN                                    Docked and rebuilt              D                               U5-15K/*Brr2*          
                                                                                                                                                                                                                                                                                                                 
  SmB                                                       196         22.4                   12-54; 76-102                                                                      4WZJ                                    Homology modelled               b                               SmB/*SmB*              
  SmD3                                                      101         11.2                   4-86                                                                               4WZJ                                    Homology modelled               d                               SmD3/*SmD3*            
  SmD1                                                      146         16.3                   1-48; 78-109                                                                       4WZJ                                    Homology modelled               h                               SmD1/*SmD1*            
  SmD2                                                      110         12.9                   17-108                                                                             4WZJ                                    Homology modelled               i                               SmD2/*SmD2*            
  SmE                                                      96           9.7                    10-63; 71-93                                                                       4WZJ                                    Homology modelled               e                               SmE/*SmE*              
  SmF                                                      86           10.4                   13-84                                                                              4WZJ                                    Homology modelled               f                               SmF/*SmF*              
  SmG                                                      77           8.5                    3-73                                                                               4WZJ                                    Homology modelled               g                               SmG/*SmG*              
                                                                                                                                                                                                                                                                                                                 
  U5 snRNA-S/-L                            179/214         68.8         1-53; 62-178           5GAN                                                                               Docked and de novo                      5                                                                                      
                                                                                                                                                                                                                                                                                                                 
  U2 snRNP                                 Msl1                          111                   12.8                                                                               28-111                                  1A9N                            Homology modelled               Y                      U2-B\"
                                                                                                                                                                                                                                                                                                                 
  Lea1                                                      238         27.2                   1-170                                                                              1A9N                                    Homology modelled               W                               U2-A\'                 
                                                                                                                                                                                                                                                                                                                 
  SmB                                                       196         22.4                   12-54; 76-102                                                                      4WZJ                                    Homology modelled               s                               SmB/*SmB*              
  SmD3                                                      101         11.2                   4-85                                                                               4WZJ                                    Homology modelled               v                               SmD3/*SmD3*            
  SmD1                                                      146         16.3                   1-48; 78-101                                                                       4WZJ                                    Homology modelled               t                               SmD1/*SmD1*            
  SmD2                                                      110         12.9                   17-108                                                                             4WZJ                                    Homology modelled               u                               SmD2/*SmD2*            
  SmE                                                      96           9.7                    10-63; 71-93                                                                       4WZJ                                    Homology modelled               w                               SmE/*SmE*              
  SmF                                                      86           10.4                   12-84                                                                              4WZJ                                    Homology modelled               x                               SmF/*SmF*              
  SmG                                                      77           8.5                    2-76                                                                               4WZJ                                    Homology modelled               y                               SmG/*SmG*              
                                                                                                                                                                                                                                                                                                                 
  Hsh155                                                    971         110.0                  132-149; 157-971                                                                   5GM6                                    Docked and rebuilt              O                               SF3B1/*Sap155*         
                                                                                                                                                                                                                                                                                                                 
  Rse1                                                     1361         153.8                  53-305; 323-571; 581-784; 814-890; 918-1265; 1292-1361                             5GM6                                    Docked and rebuilt              P                               SF3B3/*Sap130*         
                                                                                                                                                                                                                                                                                                                 
  Cus1                                                      436         50.3                   125-213; 239-353; 361-376                                                          5GM6                                    Docked and rebuilt              Q                               SF3B2/*Sap145*         
                                                                                                                                                                                                                                                                                                                 
  Hsh49                                                     213         24.5                   9-86; 106-144; 147-185; 189-203                                                    5GM6                                    Docked and rebuilt              R                               SF3B4/*Sap49*          
                                                                                                                                                                                                                                                                                                                 
  Rds3                                                      107         12.3                   2-104                                                                              5GM6                                    Docked and rebuilt              S                               SF3B14b/*Ini1*         
                                                                                                                                                                                                                                                                                                                 
  Ysf3                                                     85           10.0                   2-84                                                                               5GM6                                    Docked and rebuilt              Z                               SF3B5/*Sab10*          
                                                                                                                                                                                                                                                                                                                 
  Prp9                                                      530         63.0                   1-97; 112-378; 407-478; 503-528                                                    4DGW                                    Docked and de novo              T                               SF3A3/*Sap61*          
                                                                                                                                                                                                                                                                                                                 
  Prp11                                                     266         29.9                   34-47; 51-105; 115-136; 149-253                                                    4DGW, 5GM6                              Docked and de novo              U                               SF3A2/*Sap62*          
                                                                                                                                                                                                                                                                                                                 
  Prp21                                                     280         33.1                   89-206; 220-228                                                                    4DGW                                    Docked                          V                               SF3A1/*Sap114*         
                                                                                                                                                                                                                                                                                                                 
  U2 snRNA                                                 1175         363.8                  3-13; 30-73; 79-86; 108-122; 139-150; 1089-1109; 1115-1130; 1138-1154; 1159-1169   5LJ5, 5GM6                              Docked and de novo              2                                                      
                                                                                                                                                                                                                                                                                                                 
  U4/U6 di-snRNP                           Snu13                         126                   13.6                                                                               3-126                                   5GAN, 3JCM                      Docked and rebuilt              K                      U4/U6.U5-15.5K/*Snu13*
                                                                                                                                                                                                                                                                                                                 
  Prp31                                                     494         56.3                   42-458                                                                             5GAN, 3JCM                              Docked and rebuilt              F                               U4/U6.U5-61K/*Prp31*   
                                                                                                                                                                                                                                                                                                                 
  Prp3                                                      469         55.9                   35-71; 83-92; 100-138; 140-173; 211-224; 228-410; 413-467                          5GAN, 3JCM                              Docked and rebuilt              G                               U4/U6.U5-90K/*Prp3*    
                                                                                                                                                                                                                                                                                                                 
  Prp4                                                      465         52.4                   23-91; 108-465                                                                     5GAN, 3JCM                              Docked and rebuilt              H                               60K/*Rna4*             
                                                                                                                                                                                                                                                                                                                 
  SmB                                                       196         22.4                   12-54; 76-102                                                                      4WZJ                                    Homology modelled               k                               SmB/*SmB*              
  SmD3                                                      101         11.2                   4-85                                                                               4WZJ                                    Homology modelled               n                               SmD3/*SmD3*            
  SmD1                                                      146         16.3                   1-48; 78-119; 138-146                                                              4WZJ                                    Homology modelled               I                               SmD1/*SmD1*            
  SmD2                                                      110         12.9                   17-108                                                                             4WZJ                                    Homology modelled               m                               SmD2/*SmD2*            
  SmE                                                      96           9.7                    10-63; 71-93                                                                       4WZJ                                    Homology modelled               p                               SmE/*SmE*              
  SmF                                                      86           10.4                   12-84                                                                              4WZJ                                    Homology modelled               q                               SmF/*SmF*              
  SmG                                                      77           8.5                    2-76                                                                               4WZJ                                    Homology modelled               r                               SmG/*SmG*              
                                                                                                                                                                                                                                                                                                                 
  LSm2                                                     95           11.2                   1-90                                                                               4M7A                                    Docked and rebuilt              a                               LSm2/*LSm2*            
  LSm3                                                     89           10.0                   3-79                                                                               4M7A                                    Docked                          3                               LSm3/*LSm3*            
  LSm4                                                      172         20.3                   1-47; 64-90                                                                        4M7A                                    Docked                          j                               LSm4/*LSm4*            
  LSm5                                                     93           10.4                   4-54;61-84                                                                         4M7A                                    Docked                          o                               LSm5/*LSm5*            
  LSm6                                                     86           9.4                    11-84                                                                              4M7A                                    Docked                          z                               LSm6/*LSm6*            
  LSm7                                                      115         13.0                   26-70; 85-105                                                                      4M7A                                    Docked                          7                               LSm7/*LSm7*            
  LSm8                                                      109         12.4                   4-67                                                                               4M7A                                    Docked                          8                               LSm8/*LSm8*            
                                                                                                                                                                                                                                                                                                                 
  U4 snRNA                                                  160         51.4                   1-68; 71-79; 90-102; 131-154                                                       5GAN                                    Docked and rebuilt              4                                                      
                                                                                                                                                                                                                                                                                                                 
  U6 snRNA                                                  112         36.1                   1-9; 16-51; 55-88; 92-102; 108-112                                                 5GAN                                    Docked and de novo              6                                                      
                                                                                                                                                                                                                                                                                                                 
  tri-snRNP                                Prp6                          899                   104.2                                                                              4-26; 64-80; 98-178; 212-526; 530-896   5GAN, 3JCM                      Docked and rebuilt              J                      PRPF6/Prp7
                                                                                                                                                                                                                                                                                                                 
  Snu66                                                     587         66.4                   148-152; 159-223; 232-236; 297-323; 343-364                                                                                De novo                         E                               U5-102k/*Snu66*        
                                                                                                                                                                                                                                                                                                                 
  B complex proteins                       Snu23                         194                   22.7                                                                               11-19; 33-62; 71-118; 125-146           5F5V                            Homology modelled and de novo   L                      ZMAT2/*Snu23*
                                                                                                                                                                                                                                                                                                                 
  Prp38                                                     242         28.0                   2-64; 74-79; 83-133; 144-169; 182-209                                              5F5V                                    Homology modelled and de novo   M                               hPrp38/*Prp38*         
                                                                                                                                                                                                                                                                                                                 
  Spp381                                                    291         33.8                   98-108; 124-151; 164-173; 181-216                                                  5F5V                                    Homology modelled and de novo   N                               MFAP1/Saf3             
                                                                                                                                                                                                                                                                                                                 
  Substrate                                UBC4 pre-mRNA                135                    40.6                                                                               6-8; 51-53; 57-79                                                       Docked and de novo              I                      
                                                                                                                                                                                                                                                                                                                 
  Unknown                                                                                                                                                                         1-18; 101-111                                                           de novo                         X                      
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![B complex structure at near-atomic resolution.\
Two orthogonal views of the B complex structure. Subunits are coloured according to snRNP identity (U2, green; U4, yellow; U5, blue; U6, red; Dib1, Prp6 and Snu66, shades of yellow). B complex proteins in shades of magenta (Spp381, magenta; Prp38, light magenta; Snu23, violet).](emss-72630-f001){#F1}

![U2 snRNP architecture and interactions with the intron.\
**a**, Organisation of the U2 snRNP with subunits coloured as in [Fig. 1](#F1){ref-type="fig"}, except for Prp9 (orange), Prp11 (yellow), Prp21 (light orange), Cus1 (dark blue), Hsh49 (light blue), Rds3 (grey), and the branch point (BP) adenosine (magenta). The thumbnail highlights the U2 snRNP subcomplexes. The RES complex location (dashed brown ellipse) is indicated based on its B^act^ location[@R20],[@R21]. The non-essential 940-nucleotide insertion in yeast U2 snRNA[@R50] is disordered. A loop in the Prp11 Zn-finger (ZnF) domain is disordered in B complex, but folds over the pre-mRNA 5'SS in B^act^ (ref.[@R21]). **b**, SF3a/b proteins chaperone U2 snRNA elements and the pre-mRNA intron. The SF3a Prp9 subunit 'wedge helix' separates the intron from U2 snRNA, guiding it towards Hsh49 RRM1. Pre-mRNA nucleotides at position --12 and --17 from the branch point (BP) adenosine and its 3'-direction (black arrow) are indicated. Colours as in **a**.](emss-72630-f002){#F2}

![U2 snRNP and tri-snRNP interfaces.\
**a**, Overview of the B complex structure, showing interface A and transient interface B. The U2 snRNP (coloured as in [Fig. 1](#F1){ref-type="fig"}) was positioned relative to tri-snRNP using a subset of particles (map B2) (see [Methods](#S6){ref-type="sec"}). Tri-snRNP is shown as a surface (grey), except for Prp3 (yellow), Prp4 (light orange), the LSm ring (salmon) and Brr2 (pale cyan except for N-terminal and C-terminal RecA-1 and RecA-2 lobes shown in shades of blue and violet). **b**, Interface A. The U2 snRNP binds tri-snRNP via U2/U6 helix II and SF3b subunit Hsh155 HEAT repeats H11-13, which bind the putative Prp3 N-terminal region. The nucleotides that form the active site U2/U6 helix I in B^act^ are disordered (dashed green line). The black triangle indicates the region of Prp3 helix α4 that bends with different U2 snRNP positions. See [Extended Data Fig. 5](#F11){ref-type="fig"}. **c**, Transient Interface B. SF3b subunits Cus1 and Rse1 BPB contact Brr2 in a subset of cryo-EM particles (see [Extended Data Fig. 5a](#F11){ref-type="fig"}; [Methods](#S6){ref-type="sec"}). Colours as in **a**.](emss-72630-f003){#F3}

![B complex proteins stabilise Brr2 and U6 snRNA.\
B complex protein interactions within the pre-catalytic B complex. The extended structures of B complex proteins Spp381 (magenta), Prp38 (light magenta), and Snu23 (violet) bind the Prp8 N-terminal (Prp8^N^) domain and contact Prp8 Jab1/MPN, Brr2 C-WH, N-HLH, and N-RecA-2 domains to position Brr2 on U4 snRNA. The Snu23 Zn-finger (ZnF) and Prp38 N-terminus stabilise the U6 ACAGAGA stem, which may enable tethering of the putative pre-mRNA 5'SS at its tip (3'-direction, black arrow).](emss-72630-f004){#F4}

![Changes in the RNA network during spliceosome activation.\
B and B^act^ complexes with RNA models superimposed on transparent surfaces of spliceosome proteins. Proteins are coloured as in [Fig. 1](#F1){ref-type="fig"}, and the two structures are aligned with their U5 snRNP foot domain (black outline). The U2 3' domain and SF3a proteins are modelled based on a low-pass filtered B^act^ cryo-EM density[@R20] (EMD-4099, see [Methods](#S6){ref-type="sec"}) onto the B^act^ model[@R21] (PDB ID 5GM6). Internal stem loop, ISL; Stem loop, SL.](emss-72630-f005){#F5}

![Model for spliceosome activation from B to B^act^ complex.\
The ATP-dependent activity of Brr2 results in release of U4 snRNA, U4/U6, and tri-snRNP-specifc proteins (transition I), followed by U6 Internal stem loop (ISL) folding and U6 ACAGAGA stem unfolding (II), formation of U2/U6 helix I, ACAGAGA helix, the 5'-exon--U5 loop I basepairs (III), and the binding of the NTC, NTR and B^act^ complex proteins (IV). Proposed activation intermediates are shown in a grey box. See also [Extended Data Figs 7d](#F13){ref-type="fig"} and [8](#F14){ref-type="fig"}.](emss-72630-f006){#F6}
